Nuveen Global Equity Income Fund Class C (NQGCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
36.60
-0.11 (-0.30%)
May 8, 2025, 4:00 PM EDT
8.96% (1Y)
Fund Assets | 131.69M |
Expense Ratio | 1.86% |
Min. Investment | $3,000 |
Turnover | n/a |
Dividend (ttm) | 0.51 |
Dividend Yield | 1.38% |
Dividend Growth | -3.59% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 31, 2025 |
Previous Close | 36.71 |
YTD Return | 6.21% |
1-Year Return | 10.58% |
5-Year Return | 86.09% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 66 |
Inception Date | Sep 15, 2009 |
About NQGCX
The Nuveen Global Equity Income Fund Class C (NQGCX) seeks to provide high current income and long-term capital appreciation. NQGCX seeks to meet its investment objective by investing primarily in income producing common stocks. NQGCX invests at least 80% of its net assets in equity securities and up to 20% of the assets may be invested in debt securities.
Category World Large-Stock Value
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol NQGCX
Share Class Class C
Index MSCI World NR USD
Performance
NQGCX had a total return of 10.58% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.52%.
Top 10 Holdings
28.43% of assetsName | Symbol | Weight |
---|---|---|
Shell plc | SHEL | 3.34% |
Prudential plc | PRU | 3.26% |
Sumitomo Mitsui Trust Group, Inc. | 8309 | 3.17% |
Wells Fargo & Company | WFC | 3.15% |
AT&T Inc. | T | 3.08% |
Sanofi | SAN | 2.87% |
Broadcom Inc. | AVGO | 2.54% |
Walmart Inc. | WMT | 2.52% |
JPMorgan Chase & Co. | JPM | 2.36% |
AstraZeneca PLC | AZN | 2.14% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 31, 2025 | $0.106 | Apr 1, 2025 |
Sep 30, 2024 | $0.1183 | Oct 1, 2024 |
Jun 28, 2024 | $0.2856 | Jul 1, 2024 |
Mar 28, 2024 | $0.1513 | Apr 1, 2024 |
Dec 28, 2023 | $0.013 | Dec 29, 2023 |
Sep 29, 2023 | $0.0981 | Oct 2, 2023 |